← All organizations
Highest phase reached
Phase 3
Timeline
2000s
- Oct 1, 2003
botulism immune globulin— NDA Organization
Drugs by trial phase (2 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Marketed drugs (1)
Recent trials (6)
- NCT06112834Lead sponsorPhase 2Jun 30, 2024
- NCT03676634Overall official - principal investigatorPhase 2Feb 28, 2019
- NCT03676634Lead sponsorPhase 2Feb 28, 2019
- NCT01701999Lead sponsorPhase 2Feb 1, 2013
- NCT01701999Overall official - principal investigatorPhase 2Feb 1, 2013
- NCT01502306CollaboratorPhase 3Jun 1, 2012
Details
- Founded
- Sacramento, CA, US
- Last known activity
- Jun 30, 2024
Designations held
- Orphan drug